Percutaneous sclerotherapy in neonatal and infant head and neck lymphatic malformations: a single center experience

被引:85
作者
Cahill, Anne Marie [1 ]
Nijs, Els [1 ]
Ballah, Deddeh [1 ]
Rabinowitz, Deborah [7 ]
Thompson, Lynn [2 ]
Rintoul, Natalie [3 ]
Hedrick, Holly [4 ]
Jacobs, Ian [5 ]
Low, David [6 ]
机构
[1] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Dept Radiol, Philadelphia, PA 19104 USA
[3] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Neonatol, Philadelphia, PA 19104 USA
[4] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Gen Surg, Philadelphia, PA 19104 USA
[5] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Otorhinolaryngol, Philadelphia, PA 19104 USA
[6] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Plast Surg, Philadelphia, PA 19104 USA
[7] Alfred I duPont Hosp Children, Wilmington, DE 19803 USA
关键词
Lymphatic malformation; Doxycycline; Sclerotherapy; Neonates; Infants; DOXYCYCLINE-INDUCED HYPOGLYCEMIA; VASCULAR MALFORMATIONS; HEMOLYTIC-ANEMIA; CHILDREN; LYMPHANGIOMAS; THERAPY;
D O I
10.1016/j.jpedsurg.2011.07.004
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Purpose: To evaluate the clinical outcomes of percutaneous sclerotherapy for congenital head and neck lymphatic malformations in our institution. Materials and Methods: Over a 7-year period, 17 children (10 M, 7 F) mean age 5.8 months (5 days to 13 months) underwent 49 sclerotherapy procedures for congenital head and neck malformations. The imaging and clinical records were reviewed for each patient. Ten of 17 had macrocystic disease; 7 of 17 had microcystic disease. Imaging response was categorized by volume reductions of 0% to 25%, 25% to 50%, 50% to 75%, or 75% to 100%. A concentration of 10 mg/mL doxycycline was used routinely via catheter in 3 instillations with a dose range of 50 to 500 mg per session as per our standard protocol in 17 of 17 patients. In more recent patients, systemic doxycycline levels were obtained after instillations. Additional treatments included direct injection doxycycline (10/17), instillation of absolute ethanol (7/17) or sodium tetradecyl sulfate (4/17), or a combination of these methods. Results: Imaging improvement of >= 76% was noted in 11 of 17. Of these, 8 of 11 had macrocystic disease. Four of 17 had 51% to 75% resolution, of which 3/4 were mixed. Two of 17 children had 25% to 50% resolution with a mixed lesion. Seven of 49 peri-procedural complications: hemolytic anemia in 2 infants, hypoglycemic and metabolic acidosis in 3 neonates aged 7 to 10 days, transient hypotension during absolute alcohol instillation in 1 neonate, and self-limiting skin excoriation secondary to peri-catheter leakage of doxycycline in one neonate. Neonates prone to these systemic complications had doxycycline doses of greater than 250 mg and resulted in serum levels of >5 mu g/mL but as high as 21 mu g/mL. Delayed neural complications occurred in 7 of 49 procedures, Horner's syndromes in 4 of 49 procedures, transient left lip weakness in 1 of 49 procedures, right facial nerve palsy in 1 of 49 procedures, and transient left hemidiaphragm paralysis in 1/49 procedures. Conclusion: Our experience with catheter directed doxycycline sclerotherapy provides excellent results for large macrocystic head and neck lymphatic malformations. Microcystic and mixed lesions continue to provide a therapeutic challenge. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:2083 / 2095
页数:13
相关论文
共 32 条
[1]   Nonsurgical therapies for limpangiomas: A systematic review [J].
Acevedo, Jason L. ;
Shah, Rahul K. ;
Brietzke, Scott E. .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2008, 138 (04) :418-424
[2]   Percutaneous sclerotherapy for lymphatic malformations: A retrospective analysis of patient-evaluated improvement [J].
Alomari, Ahmad I. ;
Karian, Victoria E. ;
Lord, David J. ;
Padua, Horacio M. ;
Burrows, Patricia E. .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2006, 17 (10) :1639-1648
[3]  
APRIL MM, 1992, ARCH OTOLARYNGOL, V118, P205
[4]   Doxycycline-induced staining of permanent adult dentition [J].
Ayashoglu, E ;
Erkek, E ;
Oba, AA ;
Cebecloglu, E .
AUSTRALIAN DENTAL JOURNAL, 2005, 50 (04) :273-275
[5]  
Basaria S, 2002, SOUTHERN MED J, V95, P1353
[6]  
Burrows Patricia E., 2008, Lymphatic Research and Biology, V6, P209, DOI 10.1089/lrb.2008.1004
[7]   Doxycycline sclerotherapy as the primary treatment for head and neck lymphatic malformations [J].
Cordes, Brett M. ;
Seidel, F. Glen ;
Sulek, Marcelle ;
Giannoni, Carla M. ;
Friedman, Ellen M. .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2007, 137 (06) :962-964
[8]   Lymphangiomas in children: Percutaneous sclerotherapy with an alcoholic solution of zein [J].
Dubois, J ;
Garel, L ;
Abela, A ;
Laberge, L ;
Yazbeck, S .
RADIOLOGY, 1997, 204 (03) :651-654
[9]   Current concepts in the classification, diagnosis and treatment of vascular anomalies [J].
Ernemann, Ulrike ;
Kramer, Ulrich ;
Miller, Stephan ;
Bisdas, Sotirios ;
Rebmann, Hans ;
Breuninger, Helmut ;
Zwick, Christine ;
Hoffmann, Juergen .
EUROPEAN JOURNAL OF RADIOLOGY, 2010, 75 (01) :2-11
[10]   New treatment options for lymphangioma in infants and children [J].
Giguère, CM ;
Bauman, NM ;
Smith, RJH .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2002, 111 (12) :1066-1075